SaSPinjara Life Sciences sees Indian pharma boosting capability in high-demand therapeutics: Nandita Vijayasimha, Bengaluru Saturday, February 1, 2025, 08:00 Hrs [IST] SaSPinjara ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

About 80 million Americans fill prescriptions each year for medications to treat new instances of moderate to severe pain, ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

Samsung remains resolute in its belief that its own QLED technology is just as capable as OLED when it comes to the best-quality picture, although even it has succumbed to the popularity of the OLED ...

A smart TV is an internet-connected television that offers a range of online features, such as on-demand content from apps like BBC iPlayer, ITVX and All 4, access to streaming services like Netflix, ...

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to ...

The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a ...

The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...

The third seasons of “Yellowjackets” and “The White Lotus” arrive, along with “Clean Slate” and “Win or Lose.” By Noel Murray Some of the best shows on the streaming giant right ...